As part of the biopharmaceutical industry’s efforts to improve health outcomes for patients in underserved communities, PhRMA member companies are identifying ways to improve clinical trial diversity and reduce barriers to participation for Black and Brown communities. As these efforts continue to take shape, our… Read More »PhRMA member companies share how they are improving clinical trial diversity
The COVID-19 pandemic has left no person unaffected, but Black Americans have been disproportionately impacted. Black adults are nearly four times more likely to be hospitalized from the virus and nearly three times more likely to die from the virus than their white counterparts. At… Read More »Diversifying clinical trials and fighting disease requires equity and trust
Key takeaways: PhRMA comments to USPTO on how to make the innovation ecosystem more diverse and inclusive
Last week, PhRMA submitted comments to the United States Patent and Trademark Office (USPTO) in response to a request for comments on the National Strategy for Expanding American Innovation. PhRMA’s comments focus on the types of initiatives and efforts that could be included in a… Read More »Key takeaways: PhRMA comments to USPTO on how to make the innovation ecosystem more diverse and inclusive
President Joe Biden’s pick for CMS administrator, Chiquita Brooks-LaSure, is slated to become the first Black woman to hold the post. Her policy priorities will likely center on healthcare access, including expanding insurance coverage, and health equity.
Our industry has committed itself to making our workplaces trusting places to have complex, and sometimes difficult, conversations about diversity and inclusion.
Roughly a third of adults had a telehealth visit in the first 6 months of the pandemic, according to a new survey conducted by the Urban Institute. But not everyone who wanted a telehealth visit was able to access it, leaving some adults with unmet… Read More »Patients report unmet care needs despite rising telehealth use
Today, PhRMA released a new report prepared by TEConomy Partners, LLC that provides insights into the efforts of biopharmaceutical companies to advance diversity & inclusion (D&I) in the workplace, in the communities in which they operate and in the patient communities in which they serve.… Read More »New report highlights biopharmaceutical industry’s commitment to D&I
Strengthening a culture dedicated to patients and equity: A conversation with Percival Barretto-Ko, President of Astellas US
This year our industry has been working around the clock to combat the COVID-19 virus, including developing effective therapeutics to treat COVID-19 and vaccines to prevent future infections. Outside of the novel coronavirus, major social issues have been brought to the forefront of public discourse.… Read More »Strengthening a culture dedicated to patients and equity: A conversation with Percival Barretto-Ko, President of Astellas US
The post COVID-19 testing failing vulnerable communities appeared first on Healthy Debate.
Conversations and healthy debate about issues facing our industry and the health care system are critical to addressing some of today’s challenges and opportunities. The Catalyst welcomes guest contributors, including patients, stakeholders, innovators and others, to share their perspectives and point of view. Today, we… Read More »Sharing rebates can improve access to medicines and increase health equity
This month, PhRMA published our commitment to racial equity and inclusion in the New York Times as well as in the Informer and the AfroAmerican, DC-based, Black-owned newspapers. This public declaration is an important milestone for our industry as we continue to take concrete steps… Read More »Systemic racism is as real as any disease, and our industry is not immune
The post Low-income Ontarians facing partial claw back of federal assistance during COVID-19 appeared first on Healthy Debate.
The post COVID-19 disproportionately affects those living in poverty. And this impacts us all. appeared first on Healthy Debate.